Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

JCI's Conversations with Giants in Medicine: Yuk Ming Dennis Lo

 Lo is often called the father of noninvasive prenatal testing. After discovering fetal DNA in maternal blood, Lo catalyzed a medical revolution that has saved millions of pregnant people from having to undergo invasive tests like amniocentesis. With Lo’s pioneering technical advances, those who are pregnant can easily and reliably be screened for Rh factor mismatch, trisomies, and genetic disorders, and the implications of his work have and may go further in cancer testing, transplantation, and perhaps beyond.

Published December 15, 2022, by Ushma S. Neill

Conversations with Giants in Medicine

Related articles

A conversation with Yuk Ming Dennis Lo
Ushma S. Neill
Ushma S. Neill
Published December 15, 2022
Citation Information: J Clin Invest. 2022;132(24):e166777. https://doi.org/10.1172/JCI166777.
View: Text | PDF
Conversations with Giants in Medicine

A conversation with Yuk Ming Dennis Lo

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts